Our RT-PCR Panel for Diagnostics of Respiratory Viruses offers a parallel detection of: SARS-CoV-2, Influenza A, Influenza B and RSV.
This comprehensive approach ensures that healthcare professionals can quickly and accurately diagnose patients, leading to timely and effective treatment.
PRODUCTS
DBdirect™ Respiratory Panel 1
DBdirect Respiratory Panel 1 is a highly robust, patent-protected RT-PCR mix that eliminates the need for RNA isolation, streamlining the lab process for nasopharyngeal swabs and saliva.
RT-PCR Respiratory Panel 1
RT-PCR Respiratory Panel 1 ensures high sensitivity with an LOD 95% at two copies of SARS-CoV-2, enabling fast sample analysis in 80 minutes and compatibility with CE-IVD automated systems.
Ondřej Žítek
Lead Application Support
Key Parameters
DBdirect™: No need for RNA isolation. Highly robust, patent-protected RT-PCR mix formulation.
Significantly faster and easier laboratory process suitable for nasopharyngeal swabs and saliva.
In-house bioinformatic analysis of tens of thousands influenza genomes and thousands RSV genoms.
Regular monitoring of the occurrence of mutations and other modifications in SARS-CoV-2 genom.
Detection Parameters
Virus | Detected genes | Detected strains/sub-types | Fluorescence channel (DB-1250, DB-1251) |
|---|---|---|---|
SARS-CoV-2 | EndoRNase and Spike | All (including α, β, δ, γ, ο) | FAM |
Influenza A | Matrix protein 1 (M1), segment 7 | H1N1, H1N1-pdm, H3N2, H5N1, H7N9, H2N2, H1N2, H5N6, H9N2 | HEX |
Influenza B | Nonstructural protein 1 (NS-1), segment 8 | Victoria and Yamagata | TEX |
RSV | area RdRp | RSV-A, RSV-B | Cy5.5 |
Isolation control*/External Control** |
|
| Cy5 |
* Synthetic RNA which is added to the test sample isolation or directly to the RT-PCR reaction in the DB-1250 and DB-1252 kits ** Synthetic RNA which is added to the sample DBdirect™ RT-PCR reaction in the DB-1251 and DB-1253
Write us
sales@dianabiotech.com